Literature DB >> 329987

Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).

R W Dyke, R L Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 329987     DOI： 10.1016/s0305-7372(77)80010-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  22 in total

Review 1.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

2.  Clinical pharmacokinetics of vindesine.

Authors:  R L Nelson; R W Dyke; M A Root
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Vindesine. A review of phase-II trials.

Authors:  R J Gralla; C T Tan; C W Young
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Vindesine in the treatment of breast cancer.

Authors:  I E Smith; T J Powles
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Vindesine as a single agent in the treatment of advanced malignant melanoma.

Authors:  S Retsas; K A Newton; G Westbury
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Vindesine. A clinical trial with special reference to neurological side effects.

Authors:  R Obrist; U Paravicini; D Hartmann; G A Nagel; J P Obrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors.

Authors:  A Y Bedikian; M Valdivieso; G P Bodey; E J Freireich
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.

Authors:  K L King; G B Boder
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography.

Authors:  O van Tellingen; A L Sonneveldt; J H Beijnen; W J Nooijen; J J Kettenes-van den Bosch; C Versluis; A Bult
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study.

Authors:  C D Haas; C J Fabian; R L Stephens; J Kish
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.